Once-Weekly Exenatide in Youth With Type 2 Diabetes.

William V TamborlaneRaafat BishaiDavid GellerNaim ShehadehDalia Al-AbdulrazzaqEvelina Mánica VazquezEva KarolyTünde TrojaOrlando DoehringDebra CarterJohn MonyakC David Sjöström

Published in: Diabetes care (2022)

In youth with type 2 diabetes suboptimally controlled with current treatments, once-weekly exenatide reduced glycated hemoglobin at 24 weeks and was well tolerated.

Keyphrases

mental health
physical activity
young adults
gestational age
red blood cell